This topic contains a solution. Click here to go to the answer

Author Question: Compare the relative efficacy of methylphenidate (Ritalin), dietary restrictions (e.g., sugar, food ... (Read 66 times)

theo

  • Hero Member
  • *****
  • Posts: 698
Compare the relative efficacy of methylphenidate (Ritalin), dietary restrictions (e.g., sugar, food additives), and barbiturates in the treatment of the primary symptoms of attention deficit disorders in children.
 
  What will be an ideal response?

Question 2

What differences exist among dextroamphetamine, methylphenidate and pemoline in the treatment of ADHD?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

owenfalvey

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Ritalin reduces the core symptoms of ADHD (impulsivity, distractibility, excessive fidgetiness) in about 60-80 of ADHD children and improves most aspects of their classroom behavior and performance and interactions with their teachers and peers, but does not seem to induce substantial longterm benefits in overall cognitive functioning (e.g., I.Q.). Elimination of potential allergens like food additives and salicylates (e.g., the Feingold diet) seems to benefit a small minority (approximately 5) of ADHD children. Barbiturates (sedative-hypnotics) are not effective at all and may actually be worse than placebo in ADHD children.

Answer to Question 2

Virtually none in terms of clinical efficacy regarding the target symptoms of ADHD or their side effects, although pemoline rarely may induce hepatic toxicity that potentially can be lethal. They differ in potency (d>m>p in terms of potency), but this is of little relevance clinically. The primary advantage of pemoline over the immediate release forms of dextroamphetamine and methylphenidate was its slower onset of action, longer duration of action and lower likelihood of abuse; however, since several sustained release formulations of dextroamphetamine or methylphenidate have been developed, this is no longer a significant factor. The particular type of psychostimulant, particularly the specific sustained release formulation of dextroamphetamine and methylphenidate that is most effective for an individual patient is determined largely on the basis of trial and error.




theo

  • Member
  • Posts: 698
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Excellent

 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library